Evaluating the Comparative Effectiveness of Sodium-Glucose Transporter 2 Inhibitors (SGLT-2i) on Liver Enzymes in Patients With Nonalcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Bayesian Network Meta-Analysis of Randomized Contr
SGLT-2 inhibitors significantly improve liver and metabolic outcomes in NAFLD, with dapagliflozin, ipragliflozin, and empagliflozin offering distinct benefits, supporting personalized treatment strategies.
Institutions
- Gono University (BD)
- Dhaka Medical College and Hospital (BD)
Publication Details
- Journal
- AACE Endocrinology and Diabetes
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1016/j.aed.2025.08.007
- Primary Topic
- Geochemistry and Geologic Mapping
- Type
- article
- Field-Weighted Citation Impact
- 0.00